menu
Showcases Stock ranks

Oracle Corporation (ORCL) (ORCL)
49.83 -0.65 (-1.29%) 03-27 16:02
Open: 49.09 Pre. Close: 50.48
High: 51.6 Low: 48.5625
Volume: 20,025,303 Market Cap: 157143M
Oracle Corp is a computer software company. It sells enterprise information technology solutions, including databases, middleware, applications, and hardware. The Company primarily offers software licenses, support, and maintenance services worldwide.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 51.72 - 51.975 51.975 - 52.182
Low: 47.88 - 48.215 48.215 - 48.486
Close: 49.355 - 49.869 49.869 - 50.285
Stock Technical Analysis
Overall:     
Target: Six months: 62.52
One year: 73.03
Support: Support1: 44.99
Support2: 39.71
Resistance: Resistance1: 53.53
Resistance2: 62.52
Pivot: 46.19
Moving Averages: MA(5): 47.66
MA(20): 46.93
MA(100): 53.09
MA(250): 54.06
MACD: MACD(12,26): -0.93
Signal(12,26,9): -1.65
%K %D: %K(14,3): 81.75
%D(3): 72.69
RSI: RSI(14): 52.44
52-Week: High: 60.5
Low: 39.71
Change(%): -8.7
Average Vol(K): 3-Month: 1429673
10-Days: 2390065
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

ORCL has closed below upper band by 15.7%. Bollinger Bands are 123.6% wider than normal. The large width of the bands suggest high volatility as compared to ORCL's normal range. The bands have been in this wide range for 23 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
2020-03-24
Oracle Works With White House For Informal Testing Of Antimalarial Drugs For COVID-19 Effectiveness
Oracle Corporation (NYSE: ORCL ) is creating a website and mobile applications for collecting data on the treatment of novel coronavirus (COVID-19) patients with antimalarial drugs, the Washington Post reported Tuesday. What Happened Oracle is donating the project to the federal government, which will maintain oversight, according to the Post. The platforms will collect information from doctors about administering the drugs to their coronavirus patients to determine their effectiveness based on data outside of more established methods of clinical trials. The Trump administration is also exploring whether the participating doctors should receive bonus payments, the Post noted. President Donald Trump was convinced of the effectiveness of two antimalarial drugs, … Full story available on Benzinga.com

2020-03-24
Oracle to partner with Trump administration to collect data on use of antimalarial drugs to treat covid-19
The company’s co-founder has fueled the president’s interest in the drugs.

Financial Analysis
Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Technology
Industry:  Software - Infrastructure
Shares Out. (M) 3150.00
Shares Float (M) 2010.00
% Held by Insiders 36.36
% Held by Institutions 53.52
Shares Short (K) 38030
Shares Short Prior Month (K) 37030
Stock Financials
EPS 3.180
Book Value (p.s.) 4.500
PEG Ratio 1.24
Profit Margin 27.06
Operating Margin 35.72
Return on Assets (ttm) 8.6
Return on Equity (ttm) 55.0
Qtrly Rev. Growth 1.9
Gross Profit (p.s.) 10.003
Sales Per Share 12.625
EBITDA (p.s.) 5.197
Qtrly Earnings Growth -6.30
Operating Cash Flow (M) 13950.00
Levered Free Cash Flow (M) 10050.00
Stock Valuation
P/E 15.67
P/E Growth Ratio -0.01
P/BV 11.07
P/S
P/CF 11.25
Dividend Yield 0.02
Dividends & Splits
Dividend 0.960
Dividend Pay Date 2020-04-22
Ex-Dividend Date 2020-04-07
Forward Dividend 0.960
Last Split Date
Last Split Ratio 2

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator